Market Closed -
Other stock markets
|
Pre-market 12:05:00 | |||
149.3 USD | -0.43% | 149.8 | +0.39% |
01:06pm | J&J: encouraging results in prostate cancer | CF |
12:26pm | J&J: positive results in bladder cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 359B | |
+26.08% | 662B | |
+21.76% | 546B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.55% | 198B | |
-10.59% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Posts Higher Fourth-Quarter Earnings; Sees COVID-19 Vaccine Sales of Up to $3.5 Billion in 2022